XML 56 R36.htm IDEA: XBRL DOCUMENT
v3.24.0.1

SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Schedule of Weighted-Average Assumptions Used To Estimate the Fair Value of Options Granted | The following table presents the weighted-average assumptions used to estimate the fair value of options granted in 2023, 2022 and 2021:
| 2023 |  | 2022 |  | 2021
Expected annual dividend yield | 2.5 | % |  | 2.0 | % |  | 1.4 | %
Risk-free interest rate | 4.06 | % |  | 1.85 | % |  | 0.75 | %
Expected volatility | 49.9 | % |  | 52.8 | % |  | 51.9 | %
Expected life in years | 4.8 |  | 5.0 |  | 5.0
Schedule of Outstanding and Exercisable Options | The following table summarizes information concerning outstanding and exercisable options:
| Weighted Average
| 2023 |  | 2022 |  | 2021
| Shares |  | Weighted Avg. Exercise Price |  | Shares |  | Weighted Avg. Exercise Price |  | Shares |  | Weighted Avg. Exercise Price
Outstanding at beginning of year | 509,212 |  |  | $ | 25.65 |  |  | 463,304 |  |  | $ | 24.28 |  |  | 661,024 |  |  | $ | 19.78 |
Granted | 80,976 |  |  | $ | 28.99 |  |  | 79,025 |  |  | $ | 32.65 |  |  | 110,112 |  |  | $ | 38.02 |
Exercised | (25,967) |  |  | $ | 20.25 |  |  | (29,917) |  |  | $ | 22.87 |  |  | (196,639) |  |  | $ | 15.37 |
Canceled or expired | (22,564) |  |  | $ | 33.01 |  |  | (3,200) |  |  | $ | 26.61 |  |  | (111,193) |  |  | $ | 26.87 |
Outstanding at end of year | 541,657 |  |  | $ | 26.10 |  |  | 509,212 |  |  | $ | 25.65 |  |  | 463,304 |  |  | $ | 24.28 |
Options exercisable at year end | 333,796 |  |  |  |  | 297,889 |  |  |  |  | 223,158 |  |  |
Weighted average fair value per option granted during the year | $ | 11.30 |  |  |  |  | $ | 13.07 |  |  |  |  | $ | 18.50 |  |  |
Schedule of Options Vested and Exercisable or Nonvested, Expected to Vest (Nonvested Outstanding Less Expected Forfeitures) | The following table summarizes information about options vested and exercisable or non-vested that are expected to vest (non-vested outstanding less expected forfeitures) at December 31, 2023:
Range of Exercise Prices |  | Options Outstanding and Exercisable |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value (in millions)
$ | 5.00 |  | to | $ | 15.00 |  |  | 41,500 |  |  | $ | 5.91 |  |  | 2.74 |  | $ | 1.4 |
$ | 15.01 |  | to | $ | 25.00 |  |  | 299,579 |  |  | $ | 23.55 |  |  | 5.25 |  | 4.6 |
$ | 25.01 |  | to | $ | 35.00 |  |  | 149,988 |  |  | $ | 30.86 |  |  | 8.60 |  | 1.2 |
$ | 35.01 |  | to | $ | 45.00 |  |  | 50,590 |  |  | $ | 43.64 |  |  | 7.24 |  | 0.0 |
$ | 5.00 |  | to | $ | 45.00 |  |  | 541,657 |  |  | $ | 26.10 |  |  | 6.17 |  | $ | 7.2 |
Schedule of Unvested Stock Options | The following table reflects the activity for all unvested stock options during 2023:
| Shares |  | Weighted Average Grant- Date Fair Value
Unvested at January 1, 2023 | 211,323 |  |  | $ | 12.84 |
Granted | 80,976 |  |  | $ | 11.30 |
Vested | (65,686) |  |  | $ | 12.79 |
Forfeited | (18,752) |  |  | $ | 12.47 |
Unvested at December 31, 2023 | 207,861 |  |  | $ | 12.29 |
Schedule of Restricted Stock Award Activity | The following table reflects the activity for restricted stock awards, excluding the restricted stock issued to Directors (in millions, except shares data):
Year Granted |  | Shares Granted |  | Outstanding at December 31, 2023 |  | Rights to Cash Dividend |  | Other Participation Rights |  | Performance Award |  | Compensation Expense
|  |  |  |  |  |  |  |  |  |  |  | Year Ended December 31,
|  |  |  |  |  |  |  |  |  |  |  | 2023 |  | 2022 |  | 2021
2019 |  | 30,251 |  |  | 6,050 |  |  | Yes |  | None |  | No |  | 0.0 |  |  | 0.1 |  |  | 0.1 |
2019 |  | 149,412 |  |  | 0 |  |  | Yes |  | None |  | Yes |  | 0.0 |  |  | 0.3 |  |  | 0.1 |
2020 |  | 28,272 |  |  | 7,068 |  |  | Yes |  | None |  | No |  | 0.1 |  |  | 0.1 |  |  | 0.2 |
2020 |  | 43,330 |  |  | 0 |  |  | Yes |  | None |  | Yes |  | (0.1) |  |  | 0.1 |  |  | 0.1 |
2021 |  | 25,371 |  |  | 12,685 |  |  | Yes |  | None |  | No |  | 0.2 |  |  | 0.3 |  |  | 0.4 |
2021 |  | 32,874 |  |  | 7,836 |  |  | Yes |  | None |  | Yes |  | (0.1) |  |  | 0.2 |  |  | 0.3 |
2022 |  | 60,808 |  |  | 36,267 |  |  | Yes |  | None |  | No |  | 0.5 |  |  | 0.8 |  |  | 0.0 |
2022 |  | 32,875 |  |  | 20,544 |  |  | Yes |  | None |  | Yes |  | 0.0 |  |  | 0.6 |  |  | 0.0 |
2023 |  | 81,127 |  |  | 78,592 |  |  | Yes |  | None |  | No |  | 0.9 |  |  | 0.0 |  | 0.0
2023 |  | 56,222 |  |  | 51,150 |  |  | Yes |  | None |  | Yes |  | 0.0 |  | 0.0 |  | 0.0
|  |  |  |  |  |  |  |  |  | Total |  | $ | 1.5 |  |  | $ | 2.5 |  |  | $ | 1.2 |
Schedule of Nonvested Restricted Stock Shares Activity | The following table reflects the activity for all unvested restricted stock during 2023:
| Shares |  | Weighted Average Grant- Date Fair Value
Unvested at January 1, 2023 | 149,225 |  |  | $ | 33.24 |
Granted | 145,513 |  |  | $ | 27.50 |
Vested | (38,971) |  |  | $ | 31.79 |
Forfeited | (22,914) |  |  | $ | 29.87 |
Unvested at December 31, 2023 | 232,853 |  |  | $ | 30.22 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration